The North America Adalimumab Market is witnessing robust growth due to the increasing prevalence of autoimmune diseases, rising adoption of biologic therapies, and expanding availability of biosimilar products. The region benefits from advanced healthcare systems, strong regulatory support, and significant investments in pharmaceutical innovation and clinical research. Continuous product...